BARILARO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 801
EU - Europa 483
AS - Asia 143
SA - Sud America 5
AF - Africa 3
OC - Oceania 2
Totale 1.437
Nazione #
US - Stati Uniti d'America 785
IT - Italia 171
SE - Svezia 106
FI - Finlandia 65
IN - India 42
DE - Germania 40
SG - Singapore 37
CN - Cina 35
FR - Francia 24
UA - Ucraina 22
CA - Canada 15
GB - Regno Unito 12
JP - Giappone 12
ES - Italia 9
IE - Irlanda 5
KR - Corea 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
BE - Belgio 4
BG - Bulgaria 4
NL - Olanda 4
PT - Portogallo 4
RO - Romania 4
IR - Iran 3
PH - Filippine 3
TG - Togo 3
AU - Australia 2
BR - Brasile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
LU - Lussemburgo 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 1.437
Città #
Fairfield 99
Chandler 91
Rome 63
Ashburn 43
Helsinki 43
Houston 41
Wilmington 40
Seattle 35
Woodbridge 28
Dearborn 26
Cambridge 25
Princeton 25
Beijing 20
Plano 20
Singapore 20
San Paolo di Civitate 16
Ann Arbor 14
Millbury 13
Ottawa 12
Boston 11
Des Moines 11
Lawrence 11
Milan 10
San Diego 10
Bremen 9
Andover 8
Norwalk 8
Villaviciosa de Odon 8
Jacksonville 7
Southend 6
Dublin 5
Florence 5
Nova Gorica 5
Phoenix 5
San Mateo 5
Bologna 4
Brussels 4
Cagliari 4
Falls Church 4
Federal 4
Kirschroth 4
Porto 4
Ras al-Khaimah 4
Sofia 4
Amsterdam 3
Brooklyn 3
Bühl 3
Jeonju 3
Lissone 3
Lomé 3
Los Angeles 3
Mainz 3
Mashhad 3
Parma 3
Sacramento 3
Shinchiba 3
Siegen 3
Wissen 3
Bhubaneswar 2
Boardman 2
Canberra 2
Chagrin Falls 2
Ciampino 2
Genoa 2
Hefei 2
Kobe 2
Mykolayiv 2
Nanjing 2
Naples 2
New York 2
Santa Maria La Carita 2
Sarno 2
Tokyo 2
Torino 2
Toronto 2
Villaricca 2
Ancona 1
Barcelona 1
Caltanissetta 1
Chignolo d'Isola 1
Civitavecchia 1
Columbus 1
Cosenza 1
Goiânia 1
Guangzhou 1
Gwangju 1
Hanoi 1
Henderson 1
Honjocho 1
Incheon 1
Jeddah 1
Jiaxing 1
Kyoto 1
Lancaster 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Limite 1
London 1
Luxembourg 1
Totale 936
Nome #
Sensitization to Gibberellin-regulated protein (Peamaclein) among Italian cypress pollen-sensitized patients 123
"Delirium Day": a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 116
ENDOCARDITIS AND LYMPHOMA: WHAT IS THE THERAPY ? 90
Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease 77
Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides 74
In systemic sclerosis prolonged QTc interval is associated with reduced exercise tolerance. 71
ASIA syndrome, calcinosis cutis and chronic kidney disease following silicone injections. A case-based review 70
Left ventricular mass and intrarenal arterial stiffness as early diagnostic markers in cardiorenal syndrome type 5 due to systemic sclerosis 70
Serum uric acid as a marker of microvascular damage in systemic sclerosis patients 67
The role of antiphospholipid antibody pattern in the recurrence of thrombosis in patients with antiphospholipid syndrome 61
In systemic sclerosis skin perfusion of hands is reduced and may predict the occurrence of new digital ulcers 59
BASILAR TYPE-MIGRAINE 55
A case of renal tubular acidosis in sjogren syndrome 48
An immunodeficiency ….turning pale! 48
Acute kidney injury: nsaids abuse or more? 48
A curious case of type 2 APS 47
Obstetric outcomes in systemic sclerosis: looking inside the sealed box 40
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial 39
Cooking influence in tolerance acquisition in egg-induced acute food protein enterocolitis syndrome 37
VASCULAR RISK FACTORS IN YOUNG PEOPLE: RESULTS FROM AN OBSERVATIONAL STUDY 36
Haart therapy and nephrotoxic agents, an issue not to be neglected! 36
Posterior reversibile encephalopathy syndrome 33
When the imaging is …misleading. 31
Silicone-induced hypercalcemia in a patient who underwent sex reassignment surgery 30
Stroke awareness and vascular risk factors in youngsters: an observational study of the Italian Association against Stroke 25
Predictive value of the adjusted global anti-phospholipida syndrome score on clinical recurrence in APS patients. A longitudinal study 11
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry") 9
Fluctuation of Anti-Domain 1 and Anti-β2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies 7
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestation. A longitudinal study from a single centre 7
Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections 6
Systemic sclerosis and pregnancy outcomes. A retrospective study from a single center 6
Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review 6
The adjusted global anti-phospholipid syndrome score as predictor of damage accrual measured by damage index for APS. A longitudinal study 6
From autoinflammation to autoimmunity: old and recent findings 6
Acquired and Inherited Thrombophilia Disorders in Pregnancy 5
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities 5
Anti-NET antibodies in antiphospholipid antibody-positive patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository 4
Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia 4
The role of hyperbaric oxygen therapy in orthopedics and rheumatological diseases 4
Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome 4
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study 3
Mortality and causes of death in systemic lupus erythematosus revisited 3
Totale 1.527
Categoria #
all - tutte 4.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 0 24 12
2019/2020255 44 15 10 6 21 37 31 24 22 20 15 10
2020/2021138 17 7 32 3 0 2 3 3 37 25 6 3
2021/2022257 2 15 23 7 40 11 4 16 23 23 43 50
2022/2023405 59 71 48 27 29 50 2 32 44 11 21 11
2023/2024308 15 31 17 33 28 15 23 62 4 43 37 0
Totale 1.527